유형별 필터링

Filter By  

12월 10, 2019 News

Novotech CRO sees changing landscape in Hemato-Oncology at ASH 2019

Novotech, the Asia-Pacific CRO, attends the American Society of Hematology conference in Orla

Read more
8월 27, 2021 보고서

Clinical trial landscape of B-cell lymphoma in asia-pacific

Diffuse Large B-Cell Lymphoma (DLBCL) is the most common and the most aggressive subtype constituting nearly 70% of B-Cell Lymphomas in Asia.

다운로드
10월 12, 2022 보고서

발작성 야간 혈색소뇨증(PNH) – 아시아 태평양 – 임상시험 환경.

추정치에 따르면, 서구 국가에서는 매년 100 만 명당 1~2 건의 PNH 가 발생하는 반면, 아시아의 발병률은 매년 100 만 명당 약 10 건이다. 아시아 지역에서는 중국과 인도의 PNH 발병률이 가장 높게 나타난다.

다운로드
5월 26, 2022 보고서

Follicular lymphoma - Asia pacific - clinical Trial landscape

Owing to its large population base, Asia may account for over 40% of the estimated global incidence of Follicular Lymphoma, with China, Japan and India collectively contributing to over a quarter o

다운로드
9월 17, 2021 보고서

Clinical trial landscape of diabetes (type 2) in asia-pacific

Diabetes, which is endemic in most Western countries, is now seeing a surge in developing nations across Asia due to aging, urbanization, and changing dietary habits.

다운로드
8월 20, 2021 보고서

Clinical trial landscape of t-cell lymphomas in asia-pacific

T-cell lymphomas (TCLs) are types of non-Hodgkin’s lymphoma (NHL) that affect T lymphocytes.

다운로드
8월 22, 2022 보고서

Diffuse large b-cell Lymphoma – Asia Pacific – Clinical trial landscape

Asia accounted for nearly 70% of the global incidence of DLBCL in 2020, with Mainland China, India, and Japan contributing to a third of all DLBCL cases worldwide.

다운로드
10월 14, 2021 보고서

Clinical trial landscape Of cll in asia-pacific

CLL is one of the most common forms of leukaemia, with the Asia Pacific region showing increasing incidence. China and South Korea are among the Asian locations showing the greatest incidence.

다운로드
5월 30, 2022 Webinar

미국과 중국의 개발 및 규제 전략

바이오 연설자 및 토론자:

Watch
9월 24, 2021 News

Regional Lead CRA

THE NEXT STEP IN YOUR CLINICAL RESEARCH CAREER If you have passion for the clinical ope

Read more